In recent years, medications such as Ozempic and Wegovy (GLP-1 receptor agonists) have been hailed as game-changers in treating type 2 diabetes, and more recently, obesity. Originally developed to improve blood sugar control in diabetes, these drugs are now recognised for their ability to help reduce appetite, support weight loss, and improve other key metabolic[…]
